{
    "root": "34675093-0bcb-d858-e063-6294a90a7198",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ibuprofen",
    "value": "20250505",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "IBUPROFEN",
            "code": "WK2XYI10QM"
        }
    ],
    "indications": "carefully consider potential benefits risks ibuprofen tablets treatment options deciding ibuprofen . lowest effective dose shortest duration consistent individual patient treatment goals [ ] . ibuprofen tablets indicated relief signs symptoms rheumatoid arthritis osteoarthritis . ibuprofen tablets indicated relief mild moderate pain . ibuprofen tablets also indicated treatment primary dysmenorrhea . controlled trials establish safety effectiveness ibuprofen tablets children conducted .",
    "contraindications": "carefully consider potential benefits risks ibuprofen tablets , usp treatment options deciding ibuprofen tablets , usp . lowest effective dose shortest duration consistent individual patient treatment goals [ ] . observing response initial therapy ibuprofen tablets , usp , dose frequency adjusted suit individual patient 's needs . exceed 3200 mg total daily dose . gastrointestinal complaints occur , administer ibuprofen tablets meals milk .",
    "warningsAndPrecautions": "ibuprofen tablets , usp available following strengths , colors sizes : 400 mg ( white , oval shaped , debossed bi 4 ) bottles 100 ndc 69367-394-01 bottles 500 ndc 69367-394-05 600 mg ( white , oval , debossed bi 6 ) bottles 100 ndc 69367-395-01 bottles 500 ndc 69367-395-05 800 mg ( white , caplet , debossed bi 8 ) bottles 100 ndc 69367-396-01 bottles 500 ndc 69367-396-05",
    "adverseReactions": "ibuprofen tablets contraindicated patients known hypersensitivity ibuprofen . ibuprofen tablets given patients experienced asthma , urticaria , allergic-type taking aspirin nsaids . severe , rarely fatal , anaphylactic-like nsaids reported patients [ , anaphylactoid , , preexisting asthma ] . ibuprofen tablets contraindicated setting coronary artery bypass graft ( cabg ) surgery [ ] .",
    "indications_original": "Carefully consider the potential benefits and risks of Ibuprofen tablets and other treatment options before deciding to use ibuprofen. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see\n \n  \n                        WARNINGS\n                     ].\n\n \n                  Ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.\n                  Ibuprofen tablets are indicated for relief of mild to moderate pain. Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea.\n                  Controlled clinical trials to establish the safety and effectiveness of Ibuprofen tablets in children have not been conducted.",
    "contraindications_original": "Carefully consider the potential benefits and risks of Ibuprofen Tablets, USP and other treatment options before deciding to use Ibuprofen Tablets, USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see\n \n  \n                        WARNINGS\n                     ].\n\n \n                  After observing the response to initial therapy with Ibuprofen Tablets, USP, the dose and frequency should be adjusted to suit an individual patient's needs.\n                  Do not exceed 3200 mg total daily dose. If gastrointestinal complaints occur, administer Ibuprofen tablets with meals or milk.",
    "warningsAndPrecautions_original": "Ibuprofen tablets, USP are available in the following strengths, colors and sizes:\n                  \n                     400 mg(white, oval shaped, debossed BI 4) \n    Bottles of 100 NDC 69367-394-01 \n    Bottles of 500 NDC 69367-394-05\n\n \n                  \n                     600 mg(white, oval, debossed BI 6) \n    Bottles of 100 NDC 69367-395-01 \n    Bottles of 500 NDC 69367-395-05\n\n \n                  \n                     800 mg(white, caplet, debossed BI 8) \n    Bottles of 100 NDC 69367-396-01 \n    Bottles of 500 NDC 69367-396-05",
    "adverseReactions_original": "Ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen.\n                  Ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients [see\n \n  \n                        WARNINGS, Anaphylactoid Reactions,\n \n  and\n \n  \n                        PRECAUTIONS, Preexisting Asthma\n                     ].\n\n \n                  Ibuprofen tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery [see\n \n  \n                        WARNINGS\n                     ]."
}